Fludrocortisone
From Wikipedia, the free encyclopedia
| Image:Fludrocortisone.png | |
| Fludrocortisone
| |
| Systematic (IUPAC) name | |
| 9-fluoro-11,17-dihydroxy-17- (2-hydroxyacetyl)- 10,13-dimethyl- 1,2,6,7,8,9,10,11,12, 13,14,15,16,17- tetradecahydrocyclopenta[a]phenanthren-3-one | |
| Identifiers | |
| CAS number | 127-31-1 |
| ATC code | H02AA02 |
| PubChem | 31378 |
| DrugBank | APRD00756 |
| Chemical data | |
| Formula | C21H29FO5 |
| Mol. weight | 380.45 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | High |
| Metabolism | Hepatic |
| Half life | 3.5 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C |
| Legal status | |
| Routes | oral |
Fludrocortisone acetate is a synthetic corticosteroid with moderate glucocorticoid potency and much greater mineralocorticoid potency. It is used primarily to replace the missing hormone Aldosterone in various forms of adrenal insufficiency such as Addison's disease and the classic salt wasting (21-hydroxylase deficiency) form of congenital adrenal hyperplasia. It is occasionally used to treat orthostatic hypotension as well.
The brand name in the U.S. is Florinef. It is available in 0.1 mg tablets. Typical daily doses for mineralocorticoid replacement are between 0.05mg - 0.2mg. Renin plasma, sodium, and potassium is checked through blood tests in order to verify that the correct dosage is reached.

